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Alginates are comprised of mannuronic (M) and guluronic acid (G) and have been shown to inhibit
enzyme activity. Pancreatic lipase is important in dietary triacylglycerol breakdown; reducing pancreatic
lipase activity would reduce triacylglycerol breakdown resulting in lower amounts being absorbed by the
body.
Lipase activity in the presence of biopolymers was assessed by enzymatic assay using natural and syn-
thetic substrates. Alginate inhibited pancreatic lipase by a maximum of 72.2% (±4.1) with synthetic sub-
strate (DGGR) and 58.0% (±9.7) with natural substrate. High-G alginates from Laminaria hyperborea
seaweed inhibited pancreatic lipase to a significantly higher degree than High-M alginates from Lessonia
nigrescens, showing that inhibition was related to alginate structure.
High-G alginates are effective inhibitors of pancreatic lipase and are used in the food industry at low
levels. They could be included at higher levels in foods without altering organoleptic qualities, potentially
reduce the uptake of dietary triacylglycerol aiding in weight management.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
In the western world, dietary fats can account for 40% of energy
intake, with triacylglycerol (TAG) being the major component (Mu
& Høy, 2004). Pancreatic lipase plays an important role in the
hydrolysis of TAG with only 10–30% of hydrolysis occurring before
the duodenal phase (Hamosh & Scow, 1973).
Pancreatic lipase has become a valid target in the treatment of
obesity with the development of Tetrahydrolipstatin (orlistat)
(Drent & Vanderveen, 1993). Orlistat inhibits pancreatic lipase by
covalently modifying the active site, reducing the hydrolysis of
TAG (Borgstrom, 1988; Hadvary, Lengsfeld, & Wolfer, 1988). When
taking orlistat, the level of ingested fat excreted in the faeces can
be increased from 5% to 32% when compared to a placebo group
(Zhi et al., 1994). In the UK, 98% of all prescriptions for the treat-
ment of obesity in 2010 were for orlistat, the remaining 2% was
for Sibutramine (withdrawn 2010) (The NHS Information Centre,
2012). Gastrointestinal side effects associated with orlistat treat-
ment can often cause problems with patient compliance to the
treatment regime, with below 50% compliance, even with pharma-
cist intervention (Gursoy, Erdogan, Cin, Cesur, & Baskal, 2006; Mal-
one & Alger-Mayer, 2003). However, the gastrointestinal side
effects of orlistat may be reduced if taken concomitantly with nat-ural fibres, such as Psylliummucilloid (Cavaliere, Floriano, & Medei-
ros-Neto, 2001).
Alginates are dietary fibres consisting of a linear polymer con-
taining two epimers of uronic acid, mannuronic (M) and guluronic
acid (G) (Haug & Smidsrod, 1967). Alginates can be extracted from
the cell walls of brown seaweed or from certain bacteria. For exam-
ple, alginates are the major constituents of the vegetative capsule
of the rigid and desiccation resistant walls of metabolically dor-
mant cysts in the soil bacteria Azotobacter vinelandii (Haug &
Smidsrod, 1967).
Certain polymers have been shown to have an effect on triacyl-
glycerol hydrolysis, such as chitin–chitosan mixtures and poly-
dextrose with diethylaminoethyl groups attached (Han, Kimura,
& Okuda, 1999; Tsujita et al., 2007). Both of these polymers poten-
tially affect the substrate and the interface between substrate and
enzyme.
Alginates have previously been shown to have an inhibitory ef-
fect on gastrointestinal enzymes. In 2000 Sunderland et al., showed
that alginates reduced the activity of pepsin by an average of 52%
in vitro (Sunderland, Dettmar, & Pearson, 2000). The work identi-
fied the characteristics of alginates that correlated with the level
of pepsin inhibition (Sunderland, Dettmar, & Pearson, 2000). The
molecular weight of the alginate was key to the level of pepsin
inhibition achievable (Strugala, Kennington, Campbell, Skjak-
Braek, & Dettmar, 2005; Sunderland et al., 2000).
The previously shown bioactivity of alginate can be altered by
both sugar residue composition and molecular weight. The use of
the epimerase enzymes allow alginates to be modified to a
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residues, therefore allowing designer alginates to be produced,
which would be vital to the understanding of which characteristics
of an alginate are important in a biological system.
Here we hypothesise that pancreatic lipase activity can be
inhibited by alginates and that the extent can be modulated to a
different degree dependent on the structural characteristics of algi-
nate used. Well characterised alginates from both sources (bacteria
and seaweed) were used in this study, including alginates that
were enzymatically modified.2. Materials and methods
2.1. Materials
All alginate samples were kindly provided by Technostics Lim-
ited (Hull, UK) (Table 1). The bile acids (deoxycholate sodium salt
and taurodeoxycholate sodium salt) were both purchased from
Fluka (Buchs, Switzerland). The lipase, colipase and orlistat (tetra-
hydrolipstatin), tris(hydroxymethyl)-methylamine, 1,2 Di-o-lau-
ryl-rac-glycero-3-(glutaric acid 6-methyl resorufin ester) (DGGR),
sodium acetate, calcium chloride and acetone were all purchased
from Sigma–Aldrich (Poole, UK). The olive oil was purchased from
a local supermarket (Cooperative Foods, UK) and the aluminium
oxide was purchased from Fisher Scientific (Loughborough, UK).2.2. Lipase activity assay using DGGR as the substrate
The lipase activity assay was a modified version of the method
developed by Panteghini, Bonora, and Pagani (2001). The assay was
comprised of three solutions; solution 1, solution 2 and the lipase
solution. Solution 1; Tris buffer (50 mmol/l, pH 8.4 at 23 C), 1 mg/l
of colipase and 1.8 mM deoxycholate sodium salt. Solution 2; ace-
tate buffer (18 mmol/l, pH 4.0 at 23 C) 72 mM taurodeoxycholate
sodium salt, 0.1 mM calcium chloride and 0.24 mM DGGR. Solution
2 was mixed with a magnetic stirrer at 500 rpm and 4 C overnight.
The lipase solution contains 1 g/l of porcine pancreatic lipase in
deionised water, where 1 mg contains 60 U of lipase activityTable 1
The alginates used in this study with some of their characteristics.
Alginate source Molecular weight
1 Mannuronan (treated with epimerase) 423,767
2 Mannuronan (treated with epimerase) 262,400
3 Mannuronan (treated with epimerase) 374,800
4 Seaweed (treated with epimerase) 251,220
5 Seaweed L. hyperborea SF200 387,000
6 Seaweed (treated with epimerase) 226,550
7 Seaweed L. hyperborea SF120 195,000
8 Seaweed L. hyperborea SF/LF 295,000
9 Seaweed L. hyperborea LFR5/60 34,700
10 Mannuronan (treated with epimerase) 211,833
11 Mannuronan (treated with epimerase) 202,000
12 Mannuronan (treated with epimerase) 194,833
13 Mannuronan (treated with epimerase) 436,767
14 Seaweed Laminaria hyperborea 260,600
15 Mannuronan (treated with epimerase) 456,733
16 Seaweed L. nigrescens LF10L 75,000
17 Seaweed L. nigrescens H120L 397,000
18 Mannuronan (treated with epimerase) 442,367
19 Seaweed L. nigrescens LF120L 221,000
20 Seaweed L. nigrescens SF60 325,000
21 Seaweed Durvillea potatorum 241,067
22 Mannuronan (treated with epimerase) 438,733
23 Bacterial mannuronan 584,400
Molecular weight is in Daltons, F(G) and F(M) are the fraction of guluronate and mannuro
consecutive guluronate residues in the alginate polymer.(where one unit will hydrolyse 1.0 microequivalent of fatty acid
from a triglyceride in one hour at pH 7.4 using triacetin).
A 4 mg/ml stock solution of each polymer was prepared by
slowly adding lyophilised biopolymer to the vortex formed by vig-
orously stirring solution 1 on a magnetic stirrer. The resulting stock
solution (4 mg/ml) was then further diluted with solution 1 to
achieve 1 and 0.25 mg/ml samples. This achieved a concentration
of 3.43, 0.86 and 0.21 mg/ml, respectively in the reaction mixture.
Two controls were used in the assay, an inhibition control (100%
inhibition) and a lipase control (0% inhibition). The inhibition con-
trol contained 0.025 mg/ml orlistat added to solution 1 and the li-
pase control was the standard reaction with no inhibitors or
biopolymers. All solutions were stored at 4 C for up to 24 h.
The assay was set up over two 96 well microplates. The first
contained 15 ll of solution 2 in every well. The second plate con-
tained 180 ll of solution 1, or a concentration of biopolymer in
solution 1. 12 ll of lipase solution was also added to every well
(12 ll of deionised water for reagent blank well) on the second
plate. The two plates were incubated for 1 h at 37 C then 160 ll
of the second plate was added to the first plate to initiate the
reaction.
To calculate the percentage of lipase inhibition, the reagent
blanks were subtracted from the corresponding controls or sam-
ples and the following formula was applied:
Percentage of Lipase Inhibition ¼ 1 ððPolymer Sample
 Inhibition ControlÞ=ðLipase Control
 Inhibition ControlÞÞ  1002.3. Lipase activity assay using olive oil as the substrate
The olive oil assay system uses a modified version of the meth-
od of Vogel and Zieve (1963). The turbidimetric method measures
the reduction in turbidity that occurs following the breakdown of
TAGs to free fatty acids by lipase. Olive oil, with a specific viscosity
of 72.5 (±10), (specific viscosity used here is unitless as it is derived
from a ratio of the oil to that of water) was used throughout the
series of experiments. The olive oil was passed through aluminium
oxide (80  15 mm deep in a glass chromatography column) toF(G) F(M) N(G > 1) Lipase inhibition (%)
0.8 0.2 44 72.2
0.7 0.3 7 41.5
0.68 0.32 22 59.1
0.68 0.32 9 56.1
0.68 0.322 16.7 55.6
0.67 0.33 9 62.4
0.664 0.336 9.6 53.7
0.66 0.336 13.8 56.3
0.633 0.367 9.9 52.5
0.62 0.38 8 60.2
0.62 0.38 5 58.4
0.54 0.46 4 60.8
0.52 0.48 11 62.4
0.49 0.51 9 50.2
0.47 0.53 0 -2.3
0.45 0.553 4.4 10.4
0.45 0.551 5.9 28.3
0.44 0.56 8 64.5
0.424 0.576 4.7 15.8
0.411 0.589 3.3 35.6
0.35 0.65 4 33.5
0.17 0.83 0 38.5
0 1 0 53.2
nate residues present in the polymer determined by NMR. N(G > 1) is the number of
Fig. 1. Lipase activity using the DGGR assay measured in absorbance over time. j –
Lipase control (lipase plus substrate), . – alginate SF200 at 3.43 mg/ml (as an
example) and N – inhibition control 0.025 mg/ml orlistat. The error bars show the
standard error of the mean of 3 replicates. All enzyme inhibition is calculated with
data from 12 min as the reaction is still close to a linear phase.
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was made up to 100 ml with acetone giving a 10% solution. This is
turn was diluted 1 in 10 with acetone to achieve a 1% olive oil stock
solution. The stock solution was stored at 4 C for up to four weeks
and was used over the entire series of experiments.
For use in the assay, an olive oil substrate solution was prepared
by adding 4 ml of 1% stock olive oil solution to a heated solution
(70 C) of 100 ml 0.05 M Tris buffer at pH 8.3 containing 0.35% so-
dium deoxycholate. This solution was maintained at 70 C and
homogenised for 10 min. Once the froth had settled and the solu-
tion had returned to room temperature, the substrate solution
could be used in the assay for up to 6 h.
The enzyme solution contained 1.29 mg/ml lipase and 18 lg/ml
colipase in deionised water. Orlistat was added (0.025 mg/ml) to
the enzyme solution as an inhibition control. Biopolymers were
added to the freshly prepared substrate solution containing the ol-
ive oil to give 3.6, 0.9 and 0.23 mg/ml.
The samples were incubated at 37 C for 15 min. After the incu-
bation the substrate solution was added to the solution containing
the enzyme solution or deionised water. The assay was maintained
at 37 C and read every 5 min at 405 nm for 35 min.
To calculate the percentage of lipase inhibition, the blanks were
subtracted from their respective controls and the following equa-
tion was applied
Percentage of lipase inhibition ¼ 1 ððInhibition Control
 Polymer SampleÞ=ðInhibition Control
 Lipase ControlÞÞ  1002.4. Statistical analysis
All data were analysed using GraphPad Prism 4 statistical soft-
ware. The comparison of inhibition levels with seaweed species
was made by using a two way ANOVA. Comparison of carbohy-
drate content and inhibition was made after plotting the data
and assessing correlation using a nonparametric Spearman test.
For initial characterisation of the assay systems (DGGR and olive
oil) three replicates were used. The analysis between the level of
inhibition by alginates from two seaweed sources was tested with
a one way ANOVA with Tukey post test. All subsequent measure-
ments used six replicates. The number of replicates is shown in
each figure legend.
3. Results
Using DGGR as a substrate, the activity of lipase could be mea-
sured by the increase in absorbance (Panteghini et al., 2001). As ex-
pected, there was a marked change in the absorbance over time for
the negative control (lipase plus substrate) illustrating the maxi-
mum rate of reaction (Fig. 1), whereas, for the inhibition control
(Orlistat (0.025 mg/ml)) there was minimal change in absorbance
over time. Fig. 1 also shows that alginate could inhibit the activity
of lipase. To compare the inhibition of a range of alginates, the
absorbance at 12 min reaction time was chosen. This time point
was used because the reaction was still close to the linear phase.
Fig. 2A shows that there was a significant difference in the level
of inhibition depending on the seaweed source of the alginate. The
alginates extracted from Laminaria hyperborea seaweed inhibited
pancreatic lipase to a significantly higher degree (two way ANOVA,
p = 0.0015) than the alginates extracted from Lessonia nigrescens.
A dose dependent inhibition was seen for both sets of seaweed
alginates. Fig. 2B shows that for Laminaria hyperborea alginate the
percentage of lipase inhibition increased with increasing concen-
tration. For LFR5/60, there was a 75% relative increase in inhibition
when the alginate concentration was increased fourfold from0.21 mg/ml to 0.86 mg/ml, and a 56% increase from 0.86 mg/ml
to 3.43 mg/ml. Similarly, the increases for alginates SF120 and
SF/LF were 90% and 122%, respectively when the alginate concen-
tration was increased from 0.21 to 0.86 mg/ml, and again 64%
and 47%, respectively increased to 3.43 mg/ml. The alginate
SF200 level of inhibition increased 44% and 46% when the alginate
concentration increased from 0.21 to 0.86 and then 3.43 mg/ml.
As seen in Fig. 2, not all alginates inhibited lipase to the same
extent, even those from the same genus of seaweed. To under-
stand why the levels differed, the compositional characteristics
of the various alginates were correlated with the level of lipase
inhibition (Table 2). Statistical significant positive correlations
were found between levels of inhibition and increasing guluronate
content (F(G)), the fraction of guluronate dimers (F(GG)), the frac-
tion of guluronate trimers (F(GGG)) and the number of guluronate
blocks greater than one in the alginate polymer (N(G > 1)). Surpris-
ingly, the reciprocal correlations with mannuronate levels were
not always significant. Only F(M) and F(MG) were statistically sig-
nificant negative correlations. The range of molecular weight
tested in this study also did not have an effect on lipase inhibition
(see Table 2).
To understand the effects of alginates on lipase activity further
we decided to investigate the relationships using a different assay
system that used a natural substrate, olive oil. Lipase activity was
measured by changes in turbidity of an olive oil solution due to
the breakdown of triacylglycerol to free fatty acids and monoacyl-
glycerol. As seen with the previous assay system, alginate again
inhibited lipase activity (Fig. 3) and the levels of inhibition varied
depending on the alginate source (Fig. 4A). Although the levels of
inhibition with an olive oil substrate were lower than that shown
with the synthetic substrate, they were not significantly different.
However, the difference between the two species of alginates
was statistically significantly different (Fig. 4A) using olive oil as
the substrate. Alginates extracted from the seaweed species Lami-
naria hyperborea inhibited pancreatic lipase to a significantly high-
er degree than alginates extracted from Lessonia nigrescens
(Fig. 4A). The difference between the two alginate sources was
apparent at all concentration of alginate tested; at 3.43, 0.86 and
0.21 mg/ml with a p value of less than 0.001 for 3.43 and
0.86 mg/ml, and a p value of 0.012 for the 0.21 mg/ml.
There was less variation between the level of inhibition by the
Lessonia nigrescens alginates when comparing the two substrates;
Fig. 2. (A) Inhibition of lipase caused by Laminaria hyperborea and Lessonia
nigrescens alginates (DGGR substrate). Four alginates of differing molecular weight
are shown for Laminaria hyperborea and Lessonia nigrescens as their respective
source. Inhibition of lipase shown in this figure is for 3.43 mg/ml of alginate. The
alginates from Laminaria hyperborea species are (from left to right) LFR5/60, SF120,
SF/LF, and SF200, full characteristics can be found in Table 1. The Lessonia nigrescens
seaweed alginates are (from left to right) LF10L, LF120L, SF60 and H120L, again full
details can also be found in Table 1. Error bars shown are the standard error of the
mean of six replicates. Laminaria hyperborea alginates inhibit lipase to significantly
higher degree than Lessonia nigrescens alginates (p = 0.0015). Bars annotated with
letter ’a’ are significantly different to those with letter ’b’. (B) Concentration
dependent inhibition of lipase by the four alginates from Laminaria genus of
seaweeds (DGGR substrate). h – 0.21 mg/ml,Q – 0.86 mg/ml and j – 3.43 mg/ml.
The error bars are the standard error of the mean of six replicates.
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(±4.1) – 29.8% (±2.3) for olive oil (Fig. 4A). The same statistical dif-
ference was observed with the Laminaria hyperborea alginates
showing an overall higher level of inhibition compared to the
Lessonia nigrescens alginates, whichever substrate was used.
A dose dependent relationship for the Laminaria hyperborea algi-
nate was again demonstrated with olive oil as the substrate. Fig. 4B
shows that decreasing the concentration from 3.43 to 0.86 and then
to 0.21 mg/ml of alginate in the reaction mixture decreases the le-
vel of lipase inhibition. The same is also true for alginates extracted
from Lessonia nigrescens species seaweed (data not shown). There
was an increase of 1.7-fold and 2.3-fold in the level of inhibition
when the concentration of LFR5/60 alginate was increased from0.21 mg/ml to 0.86 mg/ml and from 0.86 mg/ml to 3.43 mg/ml. This
was also similar for the other three Laminaria hyperborea alginates.
When there was a fourfold increase in the alginate concentration
from 0.21 mg/ml to 0.86 mg/ml, there was an increase in the level
of inhibition observed, 100.0%, 76.4%, and 85.0% increase for
SF120, SF/LF, and SF200, respectively. When the concentrations of
the same alginates were increased fourfold (3.43 mg/ml), again
the level of inhibition increased 83.2%, 117.2%, and 77.4%, respec-
tively for alginates SF120, SF/LF, and SF200.
The ability of alginates to inhibit lipase was related to struc-
tural/compositional characteristics using olive oil as a substrate
as seen in Table 2. Unlike the DGGR substrate, the absolute amount
of alginate that was guluronate was not significant but as before
the F(GG), F(GGG), and N(G > 1) still correlated significantly with
lipase inhibition (Table 2).4. Discussion
The adapted methods of Panteghini et al. (2001) and Vogel and
Zieve (1963) are both effective for in vitro determination of pancre-
atic lipase activity. There are drawbacks and advantages with both
methods used in this paper. DGGR is a synthetic substrate whereas
olive oil is a natural substrate, but being a natural substrate olive
oil is a mixture of different triacylglycerol with varying acyl chain
length, which will have differing affinity for the enzyme (Jemel,
Fendri, Gargouri, & Bezzine, 2009; Rogalska, Ransac, & Verger,
1990). The enzyme would also have to act on the substrate twice
for there to be a detectable change in the optical density (OD), as
diacylglycerol would not be solubilised and therefore not reduce
the OD. This could explain the lower levels of inhibition seen using
the olive oil as a substrate compared to the DGGR substrate which
is only cleaved once.
The two methods show relatively large error bars, which can be
explained to some extent by the solubility of the substrate. This
varied between the replicates however for each experiment the
same substrate preparation has been used for the positive control,
negative control and the inhibition study.
Both methods showed that alginates are effective inhibitors of
pancreatic lipase, depending upon the structure. Alginates with a
high G block content can inhibit lipase to a much greater extent
than alginates with high M block content. Therefore, it is possible
to modulate the activity of pancreatic lipase to a varying degree
depending upon the alginates used.
Molecular weight of the alginates was not a determining factor
of inhibition and neither was viscosity as one of the best inhibitors,
LFR5/60, has a viscosity of 6 mPas compared to a poor inhibitor,
LF120L, which has a viscosity of 121 mPas (for 1% solution in phos-
phate buffered saline).
There are several potential mechanisms for inhibition of lipase
by alginate. Alginates have the potential to interact with both the
substrate and the enzyme itself. Alginates with a high G block con-
tent are known to interact with glycoprotein, specifically mucin
measured by rheological assessment across a range of mucin: algi-
nate ratios (Taylor, Draget, Pearson, & Smidsrød, 2005; Taylor,
Pearson, Draget, Dettmar, & Smidsrød, 2005). It was hypothesised
that alginate can interact with specific sites along the protein sec-
tion of the glycoprotein, cross linking several mucin molecules to-
gether forming a gel (Taylor, Draget, Pearson, & Smidsrød, 2005).
The G block content of the alginate was also key in the mucin inter-
action, as alginates with high mannuronate content would not
interact and cross link the mucin molecules. Therefore showing
that alginate can interact with protein and that G blocks are impor-
tant for this interaction.
It is also possible that alginates may associate with the oil/
water interface potentially reducing the access that lipase has to
Table 2
The Spearman’s correlation coefficient with p values of the correlation analysis of alginate characteristics against percentage of lipase inhibition with both DGGR and olive oil as
the substrate.
Alginate characteristic DGGR Olive oil
Corr. p Value Signif. Corr. p Value Signif.
F(G) 0.502 0.015 ⁄ 0.380 0.074 n/s
F(GG) 0.583 0.004 ⁄⁄ 0.514 0.012 ⁄
F(GGG) 0.578 0.004 ⁄⁄ 0.593 0.003 ⁄⁄
F(M) 0.506 0.014 ⁄ 0.380 0.074 n/s
F(MM) 0.336 0.117 n/s 0.0870 0.693 n/s
F(MG) 0.505 0.014 ⁄ 0.806 <0.0001 ⁄⁄⁄
F(MGM) 0.494 0.017 ⁄ 0.684 0.0003 ⁄⁄
F(MGG) 0.003 0.988 n/s 0.377 0.076 n/s
N(G > 1) 0.586 0.003 ⁄⁄ 0.625 0.001 ⁄⁄
Molecular weight 0.044 0.840 n/s 0.261 0.229 n/s
The characteristics of alginates, Spearman’s correlation coefficient, rs (Corr), p value and whether the correlation was statistically significant (Signif.) or not (significance is
taken as p values below 0.05). F(G) is the fraction of guluronate in the alginate, F(GG) is the fraction of guluronate dimers, F(GGG) is the fraction of guluronate trimers. F(M),
F(MM) and F(MMM) are the fraction of mannuronate, its dimers and trimers in the alginate. F(MG) and F(MGM) are the fractions of alternating dimers and trimers with
F(MGG) being the fraction of uronate trimer consisting of mannuronate and two guluronate residues specifically in that order. N(G > 1) is the number of guluronate blocks
greater than one in the alginate polymer. p Values < 0.05 are represented by ⁄, <0.005 are represent by ⁄⁄ and <0.001 are represented by ⁄⁄⁄.
Fig. 3. The absorbance change (at 405 nm) over time as a measure of lipase activity
(olive oil substrate). N – Lipase control (lipase plus substrate), . – alginate SF200 at
3.43 mg/ml (as an example) and j – inhibition control 0.025 mg/ml orlistat. The
error bars show the standard error of the mean of three replicates. All enzyme
inhibition was calculated with data from 12 min.
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tential inhibitors of pancreatic lipase such as chitosan, DEAE-
Sephadex and DEAE polydextrose, all of which however are cat-
ionic whereas alginate is anionic (Han et al., 1999; Tsujita et al.,
2007). DEAE-Sephadex and DEAE polydextrose have multiple
diethylaminoethyl groups and can reduce the activity of lipase
in vitro, which was dependent upon the degree of DEAE substitu-
tion. Increasing the degree of substitution of DEAE-polydextrose
decreased the concentration needed to inhibit 50% activity. The
concentration of polymer for 50% inhibition was 1.44, 16.9, 618,
and >1000 lg/ml when the substitution degree was 1.09, 0.18,
0.079 and 0.048, respectively. The activity returns however when
the substrate was emulsified with TritonX-100, a commonly used
(uncharged) emulsifier (Han et al., 1999; Tsujita et al., 2007), there-
fore potentially outcompeting DEAE-Sephadex and polydextrose
for space at the interface.
Isaksson, Lundquist, and Ihse (1982) showed that pectins with
low esterification could inhibit pancreatic lipase in both a buffered
system and in human pancreatic juice, with a more pronounced ef-
fect in the pancreatic juice (Isaksson et al., 1982). At higher levels
of esterification (53%), pectin has also been shown to match the
levels of inhibition achievable to that of the commercially available
drug orlistat, 82% inhibition against 88% inhibition for that of orli-
stat (Kumar & Chauhan, 2010). The authors go onto suggest that
pectin does not just interact with the substrate as is suspected to
be the case with chitosan, but can actually complex with the en-
zyme and potentially protonate serine and histidine in the active
site of the enzyme (Kumar & Chauhan, 2010). There was little de-
tail regarding the units of activity of the lipase or the concentra-
tions of substrate used in their experiment. However, in recent
tests within our laboratory, commercially available pectin with a
similar degree of esterification (60% compared to 53%) could only
achieve 11.1% inhibition with olive oil as the substrate (3.8 mg/
ml pectin against 3.4 U/ml enzyme – data not shown).
It is believed that the carboxyl groups of the pectin are involved
in the protonation of the active site residues (Kumar & Chauhan,
2010). The carboxyl groups of pectin are where methyl groups
are added via ester bonds, and increasing the level of esterification
lowers the number of carboxyl groups. This therefore may explain
why pectins with a higher level of esterification have a lower effect
on lipase activity (Isaksson et al., 1982). The carboxyl groups in G
block structures of alginate are in similar positions to that of the
backbone of pectin molecules, which is how both bind calcium.
Dietary fibres would be advantageous in the treatment of obes-
ity over conventional pharmaceutical lipase inhibitors, such as orli-stat, as high fibre products can potentially reduce or eliminate the
gastrointestinal side effects seen with orlistat treatment (Cavaliere
et al., 2001). Dietary fibres, such as pectin and alginate show evi-
dence of inhibiting lipase and could be incorporated into a wide
variety of different vehicles for delivery. Alginates may be a more
desirable candidate to take forward as an obesity treatment as they
demonstrated a far superior lipase inhibiting capacity and can eas-
ily be modified enzymatically to produce the desired
characteristics.
Alginates have previously been shown to increase fatty acid
excretion in ileostomy patients, believed to be a result of the
entrapment with the alginate matrix (Sandberg et al., 1994). The
increase in fatty acid excretion may now be explained by the algi-
nates capacity to inhibit lipase and therefore reduce the amount
absorbed by the body.
Specific alginates are effective inhibitors of pancreatic lipase
and have been used in the food and pharmaceutical industry for
many years. The inclusion of an alginate into foods (without alter-
ing taste or acceptability) has the potential to reduce the intake of
dietary triacylglycerol and could greatly help in weight
management.
Fig. 4. (A) Comparison of lipase inhibition, using olive oil as a substrate, by
alginates extracted from Laminaria and Lessonia seaweeds. Four alginates of
increasing molecular weight from left to right are shown for both Laminaria and
Lessonia as their respective source. Inhibition of lipase shown in this figure is caused
by 3.43 mg/ml of alginate. There was a statistical difference between the two
species of seaweed with p values of less than 0.001. Error bars shown are the
standard error of the mean of three replicates. Bars annotated with letter ’a’ are
significantly different to those with letter ’b’. (B) Concentration dependent
inhibition of lipase by the four alginates from Laminaria hyperborea genus of
seaweeds (olive oil substrate). h – 0.21 mg/ml,Q – 0.86 mg/ml and j – 3.43 mg/
ml. The error bars are the standard error of the mean of three replicates. The
molecular weight of the biopolymers increases from left to right (LFR5/60 to SF200).
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